Healthcare Strategy & Consulting

At Medicys, we partner with leading global strategy and consulting firms who advise healthcare business leaders on their most critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers & acquisitions. Typical projects in this space will focus on:

Market Sizing & Value Proposition development
Digital Marketing & Sales Strategy
End-to-End Patient Experience Strategy
Asset identification and acquisition
Telehealth implementation
Portfolio management and prioritisation
Patient Support Program (PSP) strategy
Strategic positioning
Competitive analysis

In practice, we do this through providing primary research services to provide the market understanding and evidence needed to support the analysis and strategic recommendations of the consulting team.

We can connect healthcare consultants with the respondents they need, be they health care professionals, KOLs and/or local, regional or national level payers, patients, patient organisations or other relevant targets to inform their strategy planning.

The properly sourced and well vetted research participants we can access are key to produce actionable insight.

Related Work

See all Work

healthcare strategy and consulting

Therapy Area: Haematology

Topic: AML and MDS

Respondent Type: Local payers

Discuss the current and future treatment landscape for AML (acute myeloid leukaemia) and MDS (myelodysplastic syndrome)

Countries:

Sample Size: 24

Methodology: 30 minute Web Assisted Telephone Depth Interviews (WATDIs)

Services Delivered: Translations, recruitment, moderation, content analyses and debrief

healthcare strategy and consulting

Therapy Area: Lab Science

Topic: Biobanks

Respondent Type: Administrators

Understand biobank capabilities, areas of expertise and opportunities for scientific collaboration

Countries:

Sample Size: 24

Methodology: 90 minute Web Assisted Telephone Depth Interviews (WATDIs)

Services Delivered: Moderation and transcripts

healthcare strategy and consulting

Therapy Area: Haematology

Topic: MM

Respondent Type: Haematologists

To understand current treatment decisions and practices in Multiple Myeloma, familiarity with the future entrants into the market (including discussing and reviewing hypothetical future product profiles) and how they may be positioned for optimal treatment of Multiple Myeloma in the future.

Countries:

Sample Size: 16

Methodology: 60 minute Web Assisted Telephone Depth Interviews (WATDIs). N=2 x vCL days.

Services Delivered: Recruitment, content analysis

healthcare strategy and consulting

Therapy Area: Hepatology

Topic: Clinically significant portal hypertension (CSPH)

Respondent Type: National KOLs

To gain and understanding of the treatment landscape for Clinically significant portal hypertension (CSPH)

Countries: